Similarly, overexpression of Ku80, another regulatory protein binding the COX-2 promoter, has been shown to increase COX-2 levels in lung cancer cells, correlating with poorer survival outcomes [31]. This evidence concerns the gene XRCC5 and lung carcinoma.